Analyst action: CVS Caremark, Synovus

By Geert De Lombaerde Posted on November 11, 2009 at 10:43 am

Scott Mushkin at Jefferies has lowered his price target on shares of CVS Caremark (Ticker: CVS) to $39 from $42 after the company’s so-so earnings call last week. He still rates the stock a ‘buy.’

Over at Morgan Keegan, Robet Patten has cut his rating on Synovus Financial to ‘market perform’ from ‘outperform.’ Shares of Synovus (Ticker: SNV) have lost three-quarters of their value this year.

permalink | Comment on this post

Tags: analyst actions, banking, CVS Caremark Corp., Jefferies & Co. Inc., Morgan Keegan & Co. Inc., pharmacy benefit management, Robert Patten, Scott Mushkin, Synovus Financial Corp.